Work

Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients.

Year: 2008

Type: article

Study design: Clinical Trial

Source: Experimental and Clinical Psychopharmacology

DOI: 10.1037/1064-1297.16.3.199

Authors: J. Eric Jensen, Melissa Daniels, Charlotte Haws, Nicolas R. Bolo, In Kyoon Lyoo, Sujung J. Yoon, Bruce M. Cohen, Andrew L. Stoll, James R. Rusche, Perry F. Renshaw

Institutions: Harvard University, McLean Hospital, Catholic University of Korea, Repligen (United States)

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Mental Health

Awards: G1680394582, MRI/MRSI Studies of Bipolar Treatment Response

OpenAlex ID: W1999945587

FWCI: 1.655

Cites: 37

Cited by: 64

Related to: 10